Hypothyroxinemia as a goal in cancer management by triiodothyronine (T3) substitution for supplemental L-thyroxine (T4) and T3 modulated hypothyroxinemia: Outcomes in a compassionate care population.
A. Hercbergs
No relevant relationships to disclose
O. Ashur -Fabian
No relevant relationships to disclose